1. Home
  2. |Insights
  3. |Navigating the New MHPAEA Final Rule: Compliance and Enforcement Insights

Navigating the New MHPAEA Final Rule: Compliance and Enforcement Insights

Webinar | 09.13.24, 12:00 PM EDT - 1:00 PM EDT

Address

Virtual

Register Here

On September 9, 2024, the U.S. Departments of Labor, Treasury, and Health and Human Services released a final rule implementing the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA). The rule clarifies and codifies the heightened standards that health plans and issuers are held to in documenting and ensuring MHPAEA compliance, amidst a landscape of increased regulatory enforcement and MHPAEA investigations. Given this heightened focus, it’s critical that plans and issuers proactively ensure compliance before regulators request required compliance documentation.

Join us for a webinar where we’ll delve into the new provisions of the rule, proactive steps for compliance, and expected enforcement and governmental trends in the coming months. Crowell & Moring’s Alice Hall-Partyka, Chris Flynn, Megan Beaver, Mike Lieberman and Spencer Bruck will share their significant experience assisting plans and issuers with proactive MHPAEA compliance and representing them through governmental inquiries and investigations.

Key Takeaways:

  • Understand the new MHPAEA rule and its implications
  • Learn proactive strategies for compliance and documentation
  • Stay informed about enforcement trends and governmental activity
  • Gain insights from experienced professionals in MHPAEA compliance and investigations

For more information, please visit these areas: Health Care

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights